A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinsons disease (the ADAGIO study): rationale, design, and baseline characteristics
What's particularly satisfying about providing these treatments is seeing clients refind activities they thought were permanently off-limits due to inflammation
Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acid
GHK-Cu ensures that the new tissue being laid down has proper collagen architecture
BPC-157 is also known as the Wolverine peptide, for its ability to help support repair and recov
Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D